Articles by Keyword for

New drugs are the poorest tested and Americans are the guinea pigs for the first few years after release. Most new drugs have new side effects reported and 20% wind up off the market or with black box warnings. The FDA does not regulate Big Pharma and has a conflict of interest position with them

New drugs are the poorest tested and Americans are the guinea pigs for the first few years after release. Most new drugs have new side effects reported and 20% wind up off the market or with black box warnings.

New drugs are problematic because they are not fully tested. Post marketing studies should be required. It is wiser to use old time-tested drugs because they've been around for decades and we know their complications. Vioxx is an interesting example. Cox 1 and Cox 2 inhibitors are explained.

We are guinea pigs whenever a new drug comes onto the market. This is especially true for drugs that are "fast tracked" through the FDA. Post approval clinical trials are required in this setting by the FDA from big pharma, but often they are not done. Older drugs that have been on the market for decades are generally better tested and safer.

A special editorial written by Donald Wright from Harvard University and published in the Journal of Law, Medicine, and Ethics pointed out that 90% of all new drugs approved by the FDA over the past 30 years are little or no more effective than drugs that are already on the market! They also commented that the safety of new FDA approved drugs is low....